University of Virginia LVG Venture Fund

University of Virginia LVG Venture Fund is a university-affiliated venture investment vehicle managed through the University of Virginia Licensing & Ventures Group. The fund supports commercialization of innovations emerging from the University of Virginia and the University of Virginia Health System, alongside related seed-funding activities. It is not an operating biotech or pharmaceutical company and does not appear to develop its own therapeutic pipeline; instead, it invests in and helps launch startups based on UVA intellectual property and other innovation opportunities. The fund has participated in healthcare-related financings, including an investment in prescription decision-support company RxRevu. Its role is best understood as an innovation commercialization and venture investor connected to UVA's tech transfer ecosystem.